PCN108 The Cost-Effectiveness of Liposomal Irinotecan and 5-Fluorouracil (5-FU)/ Leucovorin (LV) for the Treatment of Patients with Metastatic Adenocarcinoma of Pancreas WHO Have Progressed Following the Use of Gemcitabine-Related Therapies in Greece

Autor:	Alexandra Beletsi, G. Stefanou, M. Koulentaki, Georgia Kourlaba, G Gourzoulidis, M. Karamouzis, I. Boukovinas
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Cost effectiveness Health Policy Metastatic adenocarcinoma Public Health Environmental and Occupational Health Gemcitabine medicine.anatomical_structure Fluorouracil Internal medicine Medicine Liposomal Irinotecan business Pancreas medicine.drug
Zdroj:	Value in Health. 23:S442
ISSN:	1098-3015
DOI:	10.1016/j.jval.2020.08.245
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::868c7f92898251f7171b0518a1fabdcc https://doi.org/10.1016/j.jval.2020.08.245 Zobrazit plný text záznamu Full Text from ScienceDirect